Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
M.D. Anderson Cancer Center
Hoffmann-La Roche
Monte Rosa Therapeutics, Inc
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Colorado, Denver
Montreal Heart Institute
University of Alabama at Birmingham
Tempus AI